Fundraising Fox

Pliant Therapeutics

NASDAQ: PLRX

South San Francisco, US · Founded 2015 · Delaware corporation · 3 known investors

pliantrx.com ↗

Pliant Therapeutics is a clinical-stage biopharmaceutical company developing integrin-based therapeutics to treat serious diseases. The company focuses on understanding integrin biology and molecular mechanisms of pathology to create safer and more effective therapies for patients.

Biotechin /pliantrx@PliantRX

Founders & leadership

KR
Kevin RaidyDirector
SB
Suzanne BruhnDirector
JH
Johannes HullExecutive Officer
JC
John CurnutteDirector
HH
Hoyoung HuhDirector
NE
Neil ExterDirector
BC
Bernard CoulieExecutive Officer, Director
EL
Eric LefebvreExecutive Officer
CH
Charles HomcyDirector

Investors · 3

Menlo VenturesSan Francisco · $1M – $20M
Agent CapitalreportedWaltham
Third Rock VenturesreportedBoston · $100K – $5Mvia Charles Homcy · board

Reported raises · per SEC filings

Form D private placements
▶$100.4MraisedMar 2020 · 66 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bernard CoulieExecutive Officer, Director
  • Barbara HowesExecutive Officer
  • Keith CummingsExecutive Officer
  • Gayle CrowellDirector
  • Smital ShahDirector
  • Kevin RaidyDirector
  • Charles HomcyDirector
  • Neil ExterDirector
  • John CurnutteDirector
  • Suzanne BruhnDirector
  • Hoyoung HuhDirector
  • Eric LefebvreExecutive Officer
  • Johannes HullExecutive Officer
Offering amount
$100.4M
Amount sold
$100.4M
First sale
Dec 2019
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$62.1MraisedJul 2018 · 29 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kevin RaidyDirector
  • Suzanne BruhnDirector
  • Johannes HullExecutive Officer
  • John CurnutteDirector
  • Hoyoung HuhDirector
  • Neil ExterDirector
  • Bernard CoulieExecutive Officer, Director
  • Eric LefebvreExecutive Officer
  • Charles HomcyDirector
Offering amount
$62.1M
Amount sold
$62.1M
First sale
Jul 2018
Incorporated
Corporation, Delaware, 2015
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.